Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Lundbeck Limited, Iveco House, Station Road, Watford, Hertfordshire, WD17 1ET, United Kingdom
Clopixol-Acuphase 50 mg/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear, yellowish oil, practically free from particles. |
Zuclopenthixol acetate 50 mg/ml.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Zuclopenthixol |
Zuclopenthixol is a potent neuroleptic of the thioxanthene series with a piperazine side-chain. The antipsychotic effect of neuroleptics is related to their dopamine receptor blocking effect. |
| List of Excipients |
|---|
|
Thin vegetable oil (derived from coconuts) |
Clear glass ampoules containing 1 mL of zuclopenthixol acetate 5% w/v in thin vegetable oil.
The ampoules are packed in boxes of 5.
Lundbeck Limited, Iveco House, Station Road, Watford, Hertfordshire, WD17 1ET, United Kingdom
PL 00458/0063
Date of First Authorisation in the UK: 16 March 1990
Renewal of the Authorisation: 3 July 2008
| Drug | Countries | |
|---|---|---|
| CLOPIXOL | Australia, Brazil, Canada, Cyprus, Germany, Spain, France, Hong Kong, Ireland, Israel, Malta, Mexico, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
